← Back to Search

Procedure

Passive Heat Therapy for Chronic Kidney Disease

N/A

Recruiting

Led By Danielle Kirkman, PhD

Research Sponsored by Virginia Commonwealth University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age > 18 years old

Stage 2-4 CKD

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 90 minutes after intervention

Awards & highlights

Study Summary

This trial investigates the effects of far-infrared therapy on vascular & renal function in CKD patients, hypothesizing improved function & exercise capacity without kidney injury.

Who is the study for?

This trial is for adults over 18 with moderate to severe chronic kidney disease (stages 2-4). Participants should be matched in age and sex to others in the study. It's not specified who can't join, but typically those with conditions that could interfere with the treatment or skew results are excluded.Check my eligibility

What is being tested?

The study tests if a single session of whole-body passive heat therapy using far-infrared technology can improve blood vessel function and exercise capacity without harming the kidneys more in people with chronic kidney disease.See study design

What are the potential side effects?

While specific side effects aren't listed, passive heat therapy may cause discomfort like sweating or overheating. It's designed to be well-tolerated, so serious side effects are unlikely but monitoring for any impact on kidney health is crucial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am older than 18 years.

Select...

My kidney function is reduced but not severely.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 90 minutes after intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~90 minutes after intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 minutes after intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Renal Safety of Heat Therapy

Tolerability of Heat Therapy as Assessed using Validated Questionnaires of Thermal Perception

Secondary outcome measures

Conduit artery endothelial function

Exercise Capacity

Lower Limb Microvascular Function

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Experimental Arm: Whole-body Passive Heat Therapy (HT)Experimental Treatment1 Intervention

Heat therapy will be administered using an infrared sauna. The intervention duration will last 25 minutes at a temperature of 60°C.

Group II: Control Arm: Thermoneutral Control (CON)Active Control1 Intervention

The control arm will consist of 25 minutes in a thermoneutral environment to serve as a comparator condition. Participants will be exposed to the exact conditions as the intervention arm, however, the temperature of exposure will be 22°C.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Virginia Commonwealth UniversityLead Sponsor

697 Previous Clinical Trials

22,884,966 Total Patients Enrolled

Danielle Kirkman, PhDPrincipal InvestigatorVirginia Commonwealth University

Media Library

Thermoneutral Control (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT05924919 — N/A

Chronic Kidney Disease Research Study Groups: Experimental Arm: Whole-body Passive Heat Therapy (HT), Control Arm: Thermoneutral Control (CON)

Chronic Kidney Disease Clinical Trial 2023: Thermoneutral Control Highlights & Side Effects. Trial Name: NCT05924919 — N/A

Thermoneutral Control (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05924919 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there vacancies available for participants in this investigation?

"That is correct. According to clinicaltrials.gov, this investigation began recruiting on June 1st 2023 and has since been modified as of the twentieth of June 2023 - actively searching for 30 participants from a single site."

Answered by AI

What is the size of the cohort participating in this trial?

"Affirmative. According to the information posted on clinicaltrials.gov, this trial is still open for recruitment and was first listed on June 1st 2023 with its most recent update coming on June 20th of the same year. 30 individuals need to be recruited from a single site in order for it to proceed as planned."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

The Effects of Passive Heat Therapy in Patients With Chronic Kidney Disease

2023. "The Effects of Passive Heat Therapy in Patients With Chronic Kidney Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05924919.

All > Chronic Kidney Disease